Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022;13(6):1843-1844.
doi: 10.1016/j.jcmgh.2022.03.001. Epub 2022 Apr 2.

Something to mTORC About in NASH

Brian N Finck  1
Affiliations
Editorial

Something to mTORC About in NASH

Brian N Finck. Cell Mol Gastroenterol Hepatol. 2022.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Younossi Z.M., Koenig A.B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. - PubMed
    1. Uehara K., Sostre-Colón J., Gavin M., Santoleri D., Leonard K.-A., Jacobs R.L., Titchenell P.M. Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis. Cell Mol Gastroenterol Hepatol. 2022;13:1625–1647. - PMC - PubMed
    1. Quinn W.J., Wan M., Shewale S.V., Gelfer R., Rader D.J., Birnbaum M.J., Titchenell P.M. mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion. J Clin Invest. 2017;127:4207–4215. - PMC - PubMed
    1. Martínez-Arranz I., Bruzzone C., Noureddin M., Gil-Redondo R., Mincholé I., Bizkarguenaga M., Arretxe E., Iruarrizaga-Lejarreta M., Fernández-Ramos D., Lopitz-Otsoa F., Mayo R., Embade N., Newberry E., Mittendorf B., Izquierdo-Sánchez L., Smid V., Arnold J., Iruzubieta P., Pérez Castaño Y., Krawczyk M., Marigorta U.M., Morrison M.C., Kleemann R., Martín-Duce A., Hayardeny L., Vitek L., Bruha R., Aller de la Fuente R., Crespo J., Romero-Gomez M., Banales J.M., Arrese M., Cusi K., Bugianesi E., Klein S., Lu S.C., Anstee Q.M., Millet O., Davidson N.O., Alonso C., Mato J.M. Metabolic subtypes of nonalcoholic fatty liver disease patients exhibit distinctive cardiovascular risk profiles. Hepatology Epub ahead of print February. 2022;26 doi: 10.1002/hep.32427. - DOI - PMC - PubMed
    1. Newberry E.P., Hall Z., Xie Y., Molitor E.A., Bayguinov P.O., Strout G.W., Fitzpatrick J.A.J., Brunt E.M., Griffin J.L., Davidson N.O. Liver-specific deletion of mouse Tm6sf2 promotes steatosis, fibrosis, and hepatocellular cancer. Hepatology. 2021;74:1203–1219. - PMC - PubMed

MeSH terms

Substances